Change search
ReferencesLink to record
Permanent link

Direct link
Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma
Stockholm, Sweden.
Stockholm, Sweden.
Stockholm, Sweden.
Umeå University, Faculty of Medicine, Department of Surgical and Perioperative Sciences, Urology and Andrology.
Show others and affiliations
2014 (English)In: Urologic Oncology, ISSN 1078-1439, E-ISSN 1873-2496, Vol. 32, no 8, 1215-1224 p.Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: A major challenge in muscle-invasive urothelial carcinoma (UC) is to identify biomarkers that can predict disease prognosis and treatment response after cystectomy. Therefore, we analyzed the potential prognostic value of the proteins vascular endothelial growth factor receptor 2 (VEGFR2), S100A4, and S100A6 in UC.

METHODS: Retrospective outcome data and tumor specimens from 83 cystectomy patients with histologically confirmed invasive UC were included. Expression levels of VEGFR2 (also called flk-1 and KDR), S100A4, and S100A6 were analyzed in primary tumor tissue by immunohistochemistry.

RESULTS: Immunohistochemical staining and analysis of VEGFR2, S100A4, and S100A6 showed localization mainly in tumor cell cytoplasm. High VEGFR2 expression and low tumor category were independent variables associated with longer overall survival (OS) and disease-free survival, revealed by a bivariate Cox proportional hazards regression model (both P<0.001). In addition, the univariate log-rank test and the Cox model demonstrated that OS beyond 2 years was significantly greater among patients with low S100A6 expression than in those with high S100A6 expression (P = 0.017 and 0.022, respectively). Differences in tumor expression of S100A4 were not significantly associated with outcome.

CONCLUSION: In this study, VEGFR2 expression was significantly correlated with risk of disease relapse and OS in a defined cohort of patients with UC of the bladder treated by cystectomy.

Place, publisher, year, edition, pages
Elsevier, 2014. Vol. 32, no 8, 1215-1224 p.
Keyword [en]
Advanced urothelial carcinoma, S100A4, S100A6, VEGFR2
National Category
Urology and Nephrology Cancer and Oncology
URN: urn:nbn:se:umu:diva-95923DOI: 10.1016/j.urolonc.2014.04.015ISI: 000346627300018PubMedID: 24880461OAI: diva2:761723
Available from: 2014-11-07 Created: 2014-11-07 Last updated: 2015-05-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Sherif, Amir
By organisation
Urology and Andrology
In the same journal
Urologic Oncology
Urology and NephrologyCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 33 hits
ReferencesLink to record
Permanent link

Direct link